FOXY-5 manufacturers
- Foxy-5
-
- $0.00 / 1g
-
2020-05-17
- CAS:881188-51-8
- Min. Order: 1g
- Purity: 98%
- Supply Ability: 1kg
|
| Product Name: | FOXY-5 | | Synonyms: | FOXY-5;N-formyl-L-methionyl-L-alpha-aspartyl-glycyl-L-cysteinyl-L-alpha-glutamyl-L-leucine;L-Leucine, N-formyl-L-methionyl-L-α-aspartylglycyl-L-cysteinyl-L-α-glutamyl-;Foxy-5(Wnt5a peptide mimetic);Foxy 5
Discontinued
(see F746005);(2S,5S,8R,14S)-5-(2-carboxyethyl)-14-((S)-2-formamido-4-(methylthio)butanamido)-2-isobutyl-8-(mercaptomethyl)-4,7,10,13-tetraoxo-3,6,9,12-tetraazahexadecane-1,16-dioic acid | | CAS: | 881188-51-8 | | MF: | C26H42N6O12S2 | | MW: | 694.77 | | EINECS: | | | Product Categories: | | | Mol File: | 881188-51-8.mol |  |
| | FOXY-5 Chemical Properties |
| Boiling point | 1244.1±65.0 °C(Predicted) | | density | 1.368±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | form | Solid | | pka | 3.34±0.10(Predicted) | | color | White to off-white |
| | FOXY-5 Usage And Synthesis |
| Uses | Foxy 5 is a Wnt-5a-derived hexapeptide, which inhibits breast cancer metastasis in vivo by targeting cell motility. | | Definition | ChEBI: (2S)-2-[[(2S)-4-carboxy-2-[[(2R)-2-[[2-[[(2S)-3-carboxy-2-[[(2S)-2-formamido-4-(methylthio)-1-oxobutyl]amino]-1-oxopropyl]amino]-1-oxoethyl]amino]-3-mercapto-1-oxopropyl]amino]-1-oxobutyl]amino]-4-methylpentanoic acid is a peptide. | | storage | Store at -20°C |
| | FOXY-5 Preparation Products And Raw materials |
|